Franklin Resources
CNST

Franklin Resources’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Franklin Resources’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,080,251
Closed -$21.9M – 1974
2020
Q3 		$21.9M Buy
1,080,251
+128,798
+14% +$3.14M 0.01% 747
2020
Q2 		$27M Buy
951,453
+571,353
+150% +$20.6M 0.01% 675
2020
Q1 		$11.9M Buy
380,100
+130,100
+52% +$4.52M 0.01% 775
2019
Q4 		$11.8M Buy
+250,000
New +$7.22M 0.01% 862

Other funds holding CNST

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Franklin Resources's CNST Position: Q4 2020 in Review

Franklin Resources sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q4 2020, closing a stake of 1,080,251 shares — an estimated $21.9M sold.

Franklin Resources first reported a position in CNST in Q4 2019 and held it in 4 quarters. The position peaked at $27M in Q2 2020. 134 funds tracked by Wall St. Rank hold CNST as of Q4 2020.

  • Franklin Resources reported no remaining Constellation Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Franklin Resources sold 1,080,251 Constellation Pharmaceuticals, Inc. shares in Q4 2020, an estimated $21.9M.
  • Franklin Resources first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 4 quarters.
  • Franklin Resources's Constellation Pharmaceuticals, Inc. position peaked at $27M in Q2 2020.
  • 134 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q4 2020.

Based on Franklin Resources's 13F filing for Q4 2020, filed 10 Feb 2021.